Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07770334

Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.

Conditions: Procalcitonin, Infection, Internal Medicine Patients

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 1000
Sponsor: Barzilai Medical Center

Summary

Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.

Eligibility Criteria

Inclusion Criteria: * All patients hospitalized in internal medicine and geriatric wards with a diagnosis of acute infectious disease who underwent procalcitonin testing, starting in 2020. Exclusion Criteria: * Age under 18 * Causes for false positive elevated cacitonin: * Extensive burns * Major operation in the last 30 days * Major trauma in the last 30 days. * Severe pancreatitis * Cardiogenic shock * Small Cell Lung Cancer * Thyroid gland malignancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07770334). StuddyBuddy aggregates publicly available trial information.